Limited Competition - Women's Interagency HIV Study (WIHS-V) (U01)
The summary for the Limited Competition - Women's Interagency HIV Study (WIHS-V) (U01) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Limited Competition - Women's Interagency HIV Study (WIHS-V) (U01): The purpose of the Womens Interagency HIV Study V (WIHS-V) is to characterize the long-term, natural and treated history of HIV infection in the current cohort of women, and recruit and retain new women into the cohort to provide insight into the changing demographics of the HIV epidemic among women in the United States (U.S.) This Limited Competition Funding Opportunity Announcement (FOA) encourages applications from 1) current Clinical Research Sites (CRS), 2) the current Data Management and Analysis Center (WDMAC), and 3 new Clinical Research Site with capacity to enroll targeted populations of women from the Southern region of the U.S. (Alabama, Arkansas, Florida, Georgia, Kentucky, Louisiana, Mississippi, North Carolina, South Carolina, Tennessee, or Texas only). All cooperative agreement awards funded under this FOA will comprise the WIHS V epidemiologic cohort.
Federal Grant Title: | Limited Competition - Women's Interagency HIV Study (WIHS-V) (U01) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Education Health Income Security and Social Services |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-AI-12-002 |
Type of Funding: | Cooperative Agreement |
CFDA Numbers: | 93.242 |
CFDA Descriptions: | Mental Health Research Grants |
Current Application Deadline: | Feb 22, 2012 |
Original Application Deadline: | Feb 22, 2012 |
Posted Date: | November 29th, 2011 |
Creation Date: | Nov 29, 2011 |
Archive Date: | Mar 24, 2012 |
Total Program Funding: | $23,900,000 |
Maximum Federal Grant Award: | |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Additional Information on Eligibility
- Other Eligible Applicants include the following: U01 AI 35004, Bronx, NY (Montefiore Medical Center) U01 AI 31834, Brooklyn, NY (SUNY Downstate Medical Center) U01 AI 34993, Chicago, IL (Hektoen Institute for Medical Research) U01 HD 32632, Los Angeles, CA (University of Southern California) U01 AI 34989, San Francisco, CA (University of California - San Francisco) U01 AI 34994, Washington, DC (Georgetown University) U01 AI 42590, Baltimore, MD, (Johns Hopkins University) (as the WIHS Data Management and Analysis Center (WDMAC) Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
- Grant Announcement Contact
- NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]] - Similar Government Grants
- • Strategies for Controlled Release of HIV Vaccines (SCORE-H) (R01 Clinical Trial Not Allowe...
- • Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...
- • AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
- • Lethal Means Safety Suicide Prevention Research in Healthcare and Community Settings (R34 ...
- • Strategies to Improve Health Outcomes and Advance Health Equity in Rural Populations (R01 ...
- • Development of Biomarkers for Mental Health Research and Clinical Utilities: (STTR [R41/R4...
- • Development of Biomarkers for Mental Health Research and Clinical Utilities (SBIR [R43/R44...
- • Pharmacologic Agents and Drugs for Mental Disorders (SBIR [R43/R44])
- More Grants from the National Institutes of Health
- • Feasibility of Novel Diagnostics for TB in Endemic Countries (FEND for TB) (R01 Clinical ...
- • Specialized Programs of Research Excellence (SPOREs) in Cancer Health Disparities and Mino...
- • Strategies for Controlled Release of HIV Vaccines (SCORE-H) (R01 Clinical Trial Not Allowe...
- • NINDS Program Project Grant (P01 Clinical Trial Optional)
- • Centers for Research in Emerging Infectious Diseases (CREID) Network (U01 Clinical Trial N...